With increasing attention directed toward bio/pharmaceutical product safety, the importance of screening for heavy metal contamination is becoming more important. Lancaster Laboratories offers an array of testing services for a variety of applications that contribute to product integrity, including drug substance and raw materials assays, cleaning validation, media screening, extractable/leachable studies and final product assay.
Our expertise and instrumentation enable analysts to offer a wide range of assays according to pharmacopeias (USP, EP, BP, JP, etc.), including support for the launch of USP 233 chapter for metals testing, as well as other customer specifications. Capabilities are available using ICP-MS, ICP-OES, Flame AA, Graphite Furnace AA and Cold Vapor AA (mercury).
In order to develop the best approach, the Metals Team begins by determining whether the application requires validated or non-validated methods. A fully validated approach may require multiple methods, depending on the material and metals. A critical step in determining the most appropriate analytical approach is to address the following key criteria:
We provide a number of approaches that can be used to perform Heavy Metals Testing and offer pricing strategies to match a selected approach, including the following tests:
We will help determine the instrumentation that best meets testing needs and provide general instrument performance guidelines, which may vary by method. For example, sensitivity limits are dependent on sample digestion approach, sample mass and instrument wavelength.
Request a quote to start working with us today. Or call one of our Business Development Specialists at 717-656-2300.
Copyright 2012 Lancaster Laboratories, Inc. All rights reserved Privacy Statement | Terms and Conditions